The tally, one vote per house
89 of 98 research houses agree, +3 houses in 30 days. See which houses, free →
Researchers across 98 houses argue that ongoing AI infrastructure spending keeps demand strong for chipmakers and technology companies, with 89 houses holding this view and 3 in the mixed group. Supporting points include AI compute demand still outstripping supply, hyperscaler capex plans, and memory chip prices expected to keep rising. A smaller group of 6 houses takes the opposite view, with concerns centred on the heavy financing needed to fund the buildout and the rate sensitivity of AI investment.
Each house counts once: its newest view on the theme in the last 60 days. The counts are computed, not written by AI; the summary is AI-written from the houses’ views, without names.
Who the houses are
- Asset managers37
- Banks30
- Independent research firms16
- Podcasts15
Types only: names are shown to members. See who said what, free →
Houses discussing it, 12 weeks
Houses with a view in the 60 days to each week’s end. Latest: 98 houses on 3 Nov.
What the theme implies
- US tech equities higher
- Asian semiconductor stocks higher
Positioning
Source: CFTC Commitments of Traders; FinChiefs calculations. Report of 27 Oct 2026. Positioning data →
Named in research
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Questions
What is the “AI chips” theme?
Ongoing AI infrastructure spending keeps demand strong for chipmakers and technology companies. It is one of 70 themes FinChiefs counts across published research from banks, asset managers, independent research firms and podcasts.
How many research houses agree?
89 of 98 research houses agree (91%), counting each house's newest view in the last 60 days: 89 agree, 3 are mixed and 6 disagree. That is +3 houses in 30 days. Members see each house by name.
Which instruments do research houses name for this theme?
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.